MENU
+Compare
THAR
Stock ticker: NASDAQ
AS OF
Jun 5, 04:58 PM (EDT)
Price
$1.51
Change
-$0.07 (-4.43%)
Capitalization
4.19M

THAR Tharimmune Inc. Forecast, Technical & Fundamental Analysis

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases... Show more

THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for THAR with price predictions
Jun 04, 2025

THAR in upward trend: 10-day moving average crossed above 50-day moving average on May 05, 2025

The 10-day moving average for THAR crossed bullishly above the 50-day moving average on May 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on THAR as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for THAR just turned positive on June 02, 2025. Looking at past instances where THAR's MACD turned positive, the stock continued to rise in of 30 cases over the following month. The odds of a continued upward trend are .

THAR moved above its 50-day moving average on May 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where THAR advanced for three days, in of 135 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 43 cases where THAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for THAR moved out of overbought territory on May 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THAR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THAR broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.137) is normal, around the industry mean (16.306). P/E Ratio (0.023) is within average values for comparable stocks, (59.921). THAR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (265.014).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. THAR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THAR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

THAR is expected to report earnings to fall 98.75% to -5 cents per share on November 29

Tharimmune Inc. THAR Stock Earnings Reports
Q3'23
Est.
$-0.05
Q2'23
Missed
by $3.84
Q1'23
Missed
by $5.52
The last earnings report on August 30 showed earnings per share of -400 cents, missing the estimate of -15 cents. With 23.78K shares outstanding, the current market capitalization sits at 4.19M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1200 Route 22 East
Phone
+1 908 955-3140
Employees
3
Web
https://www.hillstreambio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEG9.170.10
+1.10%
Leggett & Platt
CXAI1.060.01
+0.95%
CXApp
SONN1.17N/A
N/A
Sonnet BioTherapeutics Holdings Inc
RL277.86-3.96
-1.41%
Ralph Lauren Corp
SNCY11.70-0.20
-1.68%
Sun Country Airlines Holdings

THAR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+1.02%
INSM - THAR
74%
Closely correlated
+0.83%
RAIN - THAR
52%
Loosely correlated
+22.50%
CMND - THAR
50%
Loosely correlated
-4.18%
SNGX - THAR
46%
Loosely correlated
-2.56%
AGIO - THAR
37%
Loosely correlated
+1.98%
More

Groups containing THAR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+1.02%
THAR
(2 stocks)
20%
Poorly correlated
-2.74%